Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.
| Website: | www.valeant.com |
| Email: | ir@valeant.com |
| Main Phone: | +1 514 744-6792 |
| Address: | 2150 Street Elzéar Boulevard West |
| State: | QC |
| City / Town: | Laval |
| Country: | CAN |
| Postal Code: | H7L 4A8 |
| Exchange: | NDD |
| CEO: | Joseph C. Papa |
| Employees: | 20700 |
| NAICS: | Pharmaceutical Preparation Manufacturing (325412) |
Gathering Data... Please wait Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.
| Website: | www.valeant.com |
| Email: | ir@valeant.com |
| Main Phone: | +1 514 744-6792 |
| Address: | 2150 Street Elzéar Boulevard West |
| State: | QC |
| City / Town: | Laval |
| Country: | CAN |
| Postal Code: | H7L 4A8 |
| Exchange: | NDD |
| CEO: | Joseph C. Papa |
| Employees: | 20700 |
| NAICS: | Pharmaceutical Preparation Manufacturing (325412) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume 0 | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange NDD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 27 | 63 |
| Number of Buys | 23 | 48 |
| Number of Sells | 4 | 15 |
| Net Activity | 171100 | -532589 |
| Last 10 Buys | Shares |
|---|---|
| Bruno Deschamps | 1,000 |
| Paul S. Herendeen | 1,000 |
| Joseph C. Papa | 1,000 |
| Bruno Deschamps | 1,000 |
| John A. Paulson | 1,000 |
| Bruno Deschamps | 1,000 |
| John A. Paulson | 1,000 |
| Bruno Deschamps | 1,000 |
| Bruno Deschamps | 1,000 |
| Bruno Deschamps | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| John A. Paulson | 1,000 |
| John A. Paulson | 1,000 |
| William A Ackman | 1,000 |
| J. Michael Pearson | 1,000 |
| J. Michael Pearson | 1,000 |
| J. Michael Pearson | 1,000 |
| Jeffrey W. Ubben | 1,000 |
| Jeffrey W. Ubben | 1,000 |
| Jeffrey W. Ubben | 1,000 |
| Jeffrey W. Ubben | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 35 | 35 | 35 | 35 |
| Low Target Price Estimate | 9 | 9 | 9 | 9 |
| Mean Target Price Estimate | 19.83 | 19.67 | 19.67 | 19.83 |
| Standard Deviation | 7.09 | 6.98 | 6.98 | 7.09 |
| Date of Most Recent Estimate | 06/01/18 | 05/22/18 | 05/22/18 | 06/01/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| SD | Specialized Disclosure Report | 7 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-06 |
| 8-K | Report of unscheduled material events or corporate changes. | 446 | 2018-06-01 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2018-05-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-05-14 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2018-05-10 |
| 4/A | Amendment to a previously filed Form 4 | 1 | 2018-05-08 |
| 4/A | Amendment to a previously filed Form 4 | 1 | 2018-05-08 |
| 4/A | Amendment to a previously filed Form 4 | 1 | 2018-05-08 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 7 | 5 | 5 | 5 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 3 | 4 | 4 | 3 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 3 | 3 | 3 | 4 |
| Mean Rec. | 2.38 | 2.67 | 2.67 | 2.83 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
